Find your next paid study

THRIVE: Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events

In this study, tocilizumab-aazg (TYENNE) will be administered to see whether tocilizumab-aazg is safe in patients with a burst brain aneurysm and if it may pre…